Replimune Group, Inc. reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported net loss was USD 42.25 million compared to USD 27.31 million a year ago. Basic loss per share from continuing operations was USD 0.78 compared to USD 0.53 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.465 USD | +4.99% | +41.56% | -11.51% |
03:04pm | HC Wainwright Adjusts Price Target on Replimune to $17 From $12, Maintains Buy Rating | MT |
06-06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.51% | 437M | |
+53.65% | 59.28B | |
+41.42% | 40.94B | |
-5.42% | 40.17B | |
-5.16% | 28.69B | |
+12.75% | 26.63B | |
-20.85% | 18.89B | |
+30.13% | 12.46B | |
+0.65% | 12.42B | |
+26.62% | 12.26B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Replimune Group, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022